Gregory Vladimer

Gregory Vladimer is co-founder and CEO of Graph Therapeutics, a techbio startup focusing on disrupting discovery in the I&I space using perturbation of complex disease samples, functional and multi-omics endpoints, and foundation models. Gregory Vladimer is on the Advisory Board of Turbine. He is the ex-VP of Translational Research and the Multimodal Discovery Lab at Exscientia. He attended UMass Chan Medical School from 2008 to 2013, where he obtained a PhD in immunology.